Bone Marrow Grafting for Leukemia and Lymphoma

This study is currently recruiting participants.

Verified by Stanford University, September 2008

Sponsors and Collaborators:	Stanford University National Cancer Institute (NCI) National Institutes of Health (NIH)
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00186147

Purpose

Bone Marrow Grafting for Leukemia and Lymphoma

Condition	Intervention
Leukemia Lymphoma Hematologic Diseases	Procedure: collection and storage of tissue samples for research

MedlinePlus related topics: Bone Marrow Transplantation Leukemia, Adult Acute Leukemia, Adult Chronic Leukemia, Childhood Lymphoma

U.S. FDA Resources

Study Type:	Observational
Official Title:	Bone Marrow Grafting for Leukemia and Lymphoma

Further study details as provided by Stanford University:

Estimated Enrollment:	9999
Study Start Date:	March 1988

Detailed Description:

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.

Eligibility

Ages Eligible for Study:	up to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate
 Exclusion Criteria:- Subject does not agree to participate

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186147

Locations

United States, California
Stanford University School of Medicine	Recruiting
Stanford, California, United States, 94305
Contact: BMT Referrals 650-723-0822 cctoffice@stanford.edu
Contact: Cancer Clinical Trials Office (650) 498-7061
Principal Investigator: Robert S Negrin
Sub-Investigator: Karl G. Blume
Sub-Investigator: Sandra Jeane Horning
Sub-Investigator: Laura Johnston
Sub-Investigator: Judith Anne Shizuru
Principal Investigator: David Miklos

Sponsors and Collaborators

Stanford University

National Cancer Institute (NCI)

National Institutes of Health (NIH)

Investigators

Principal Investigator:	David Miklos	Stanford University
Principal Investigator:	Robert S Negrin	Stanford University

More Information

Study ID Numbers:	BMT19, 13358, BMT19, NCT00186147
Study First Received:	September 13, 2005
Last Updated:	October 3, 2008
ClinicalTrials.gov Identifier:	NCT00186147
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lymphatic Diseases
Leukemia
Immunoproliferative Disorders

Hematologic Diseases
Lymphoproliferative Disorders
Lymphoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type
Immune System Diseases

ClinicalTrials.gov processed this record on January 15, 2009